Ozempic Maker's Parent Company To Invest $7B Annually By 2030: 'We Have More Money Than Ever To Invest'

  • 6 months ago
Novo Holdings’ CEO, Kasim Kutay, highlighted that the increasing income from its investments and the success of Novo Nordisk’s drugs like Ozempic and Wegovy drive this decision. The fund surge will be equally distributed between capital and life sciences investments.
Transcript
00:00 [MUSIC PLAYING]
00:03 [MUSIC PLAYING]
00:06 [MUSIC PLAYING]
00:10 [MUSIC PLAYING]
00:13 [MUSIC PLAYING]
00:17 [MUSIC PLAYING]
00:21 [MUSIC PLAYING]
00:26 [MUSIC PLAYING]
00:30 [MUSIC PLAYING]
00:35 [MUSIC PLAYING]
00:40 (upbeat music)
00:42 (upbeat music)
00:45 (upbeat music)
00:47 (upbeat music)
00:53 (upbeat music)
00:57 (upbeat music)
01:02 (upbeat music)
01:04 (upbeat music)
01:07 you

Recommended

0:36
I
Up next
Ulta Beauty's Earnings Miss Expectations as Same-Store Sales Decline. CEO Dave Kimbell Attributes Defends Company's Engagement and Operations.
Benzinga
0:40
Dell Sees 9% Revenue Boost as AI-Optimized Server Sales Surge. AI Server Backlog Hits $3.8 Billion Amid Revenue Growth
Benzinga
0:39
Lululemon Misses Revenue Target for First Time in Two Years Amid Botched Launch. CEO Defends Brand's Strength
Benzinga
0:42
Nvidia May Invest $100 Million in OpenAI, Joining Apple and Microsoft. Massive Funding Round Could Value the AI Startup at Over $1 Billion.
Benzinga
7:24
Citius Pharmaceuticals (NASDAQ: $CTXR): Late-Stage Assets, Strategic Mergers & Upcoming Catalysts
Benzinga
0:29
Former First Lady Melania Trump Opens Up About Emotional Journey of Writing Her Memoir as It Climbs up Amazon's Best Sellers List Ahead of Release Date
Benzinga
4:27
Rivian Stock Drops on Q1 Loss, Weak Guidance, Announces Layoffs (NASDAQ:RIVN)
Benzinga
5:13
Is This A Buy The Dip Opportunity In The Stock Market?
Benzinga
4:12
No Bid For Defensives and What Are The Bond Markets Telling Us? - Cameron Dawson, CFA, Chief Investment Officer, NewEdge Wealth
Benzinga
4:50
"Oversold in an uptrend tends to work a lot better than overbought in a downtrend" - Cameron Dawson, CFA, Chief Investment Officer, NewEdge Wealth
Benzinga
2:17
Is Nvidia The Whole Stock Market, What Does The Data Say?
Benzinga
1:59
Are we in an earnings recession? - Marc Chaikin, Founder of Chaikin Analytics
Benzinga
7:13
From Meme to Market: Apu Apustaja's Journey to a $380M Market Cap
Benzinga
2:54
What do you do when a stock passes the analyst target price? - $NVDA
Benzinga
4:15
Go Woke, Go Broke, ETF and GUNZ ETF, Matthew Tuttle, Tuttle Capital Management
Benzinga
2:26
Intel Q4 Earnings Highlights: Shares Trade Lower, Revenue Beat, EPS Beat, Guidance Disappoints, 'Executing Our Mission To Bring AI Everywhere'I
Benzinga
1:31
Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree
Benzinga
7:20
Looking At Short Volume In The S&P 500 Over The Past Year, What Is It Saying About Stocks Now?
Benzinga
0:39
Asana Announces $150 Million Stock Buyback: What To Know
Benzinga
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
19:06
Is The A.I. Story Real Or Are We In A Bubble? Todd Gordon, Founder of Inside Edge Capital
Benzinga
2:04
Is Nvidia Worthy Of Its Price? - $NVDA
Benzinga
4:58
Year End Market Call And Has The Market Reached A Bottom? Tommy Lackey, Managing Partner at Relativity Capital Advisors
Benzinga
2:44
After the recent rally in A.I. stocks, where do we stand in that sector? - $NVDA $META $GOOG $AMZN
Benzinga
0:43
Ozempic Weight Loss Drug Maker Is Making Money Hand Over Fist - And Just Raised Its Profit Forecast
Benzinga